ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SIGA vs PYXS // EV/EBITDA & P/E VALUATION

SIGA Technologies Inc. (NASDAQ) VS. Pyxis Oncology Inc. (NASDAQ) • 15-METRIC TALLY: SIGA 6 — PYXS 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIGA VS. PYXS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SIGA PYXS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 68.60% 82.80% -14.20 PYXS /gross-margins <GO>
Return on Invested Capital (ROIC) 42.70% -35.00% +77.70 SIGA /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 4.8x — — TIE /valuation <GO>
Free Cash Flow Yield 19.03% — — TIE /fcf-yield <GO>
Operating Margin 25.10% -60.00% +85.10 SIGA /operating-margins <GO>
Net Profit Margin 24.60% -60.00% +84.60 SIGA /net-margins <GO>
Revenue Growth (YoY) -31.80% -14.20% -17.60 PYXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.22 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 SIGA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.7 34.8 +1.88 SIGA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 9.1x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $228.5M $226.0M $2.5M SIGA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SIGA REV PYXS REV SIGA GROSS % PYXS GROSS % SIGA FCF PYXS FCF
FY 2025 $94.6M $13.9M 68.6% 82.8% $43.5M -$63.5M
FY 2024 $138.7M $16.1M 77.4% 97.1% $48.8M -$57.9M
FY 2023 $139.9M $0 — — $94.8M -$70.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIGA // BETA —
PYXS // BETA —